News
IO Biotech plans to meet with the FDA this fall to discuss the data from the phase 3 trial of Cylembio and determine next ...
A new cancer drug that can be injected directly into tumors eradicated breast cancer and melanoma metastases in a handful of ...
Q2 2025 Earnings Call Transcript August 15, 2025 Operator: Good afternoon, ladies and gentlemen, and welcome to the Celcuity ...
According to SDIC Securities, the global AI-driven drug market has more than doubled since 2021, hitting $1.76 billion in ...
ScaleReady awards multiple G-Rex grants to leading investigators at the USC and CHLA: St. Paul, Minnesota Saturday, August 16, 2025, 12:00 Hrs [IST] ScaleReady in collaboration wi ...
23h
Zacks Small Cap Research on MSNBCLI: Focused on Initiation of Phase 3b ENDURANCE Trial of NurOwn® in ALS…
BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...
New findings reveal promising efficacy of irpagratinib and atezolizumab in treating advanced hepatocellular carcinoma with ...
Cidara Therapeutics, Inc.'s CD388 shows promise as a superior flu prophylactic. Click for strong trial results, upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results